| [1] |
ZHANG Jing, WANG Xin, WANG Pengmin, GUO Pei, CHANG Yike, LIU Qing, LIU Huimin, MIAO Guoying. Expression of P62 and Casepase-8 in the lesions of basal cell carcinoma[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(11): 657
-659
. |
| [2] |
CHEN Wenhui, LUO Zhenshou, YUAN Jun, YANG Zuqing, TIAN Lishan. Intra-familial transmission of leroy: two cases report[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(11): 686
-687
. |
| [3] |
SUN Xianqi, LI Yuzhen.. Update of Muir-Torre syndrome[J]. China Journal of Leprosy and Skin Diseases, 2017, 33(8): 510
-512
. |
| [4] |
LI Boping CHAN Baihui ZHU Lei WU Yi. Cutaneous anthrax:3 cases report and literatures review[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(3): 146
-149
. |
| [5] |
YANG Songbiao, NIU Zhengxiang, WANG Jingquan, CHEN Xu, QIAN jianrong, XU Hongxia.. Effects of Selfcare Group in preventing leprosy disability[J]. China Journal of Leprosy and Skin Diseases, 2017, 33(10): 589
-591
. |
| [6] |
CHEN Hongying, CHEN Xu, GU Heng.. Update of biological agents in the treatment of moderate to severe atopic dermatitis[J]. China Journal of Leprosy and Skin Diseases, 2017, 33(12): 748
-751,762
. |
| [7] |
XU Ping, ZHAO Xiao-xing.. Asessment of Danggui Kushen pills combined with blue/red light and tretinoin cream in the treatment of moderate acne[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(1): 18
-19
. |
| [8] |
ZHOU Qiong-yan, YE Xiao-lei, XU Su-ling, PENG Lan. Expression of IL-17 and IL-22 in the patients with pityriasis rosea[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(1): 22
-23
. |
| [9] |
JIANG Hongwei, WANG Xiuqin, WANG Hong, ZHANG Fengtao, LI Li, YIN Deqing . Analysis of HIV Voluntary Counseling and Testing (VCT) in Linyi City from 2010-2015[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(7): 414
-417
. |
| [10] |
WANG Zhenzhen, LIU Hong, ZHANG Furen. Risk prediction model of leprosy based on the susceptibility genes and its power study[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(10): 581
-583
. |
|